News and Trends on Pharma Industry Production & Manufacturing

CordenPharma Seals AmbioPharm Deal to Expand Global Network

Yuvraj — Sat, 30 May 2026 08:25:37 +0000

CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm Deal strengthens the company’s manufacturing presence in the United States while adding newly integrated production capabilities in Shanghai, China. The move allows CordenPharma to comprehensively support the growing global demand for […]

The post CordenPharma Seals AmbioPharm Deal to Expand Global Network first appeared on World Pharma Today.

SK Bioscience Inks Colombia Vaccine Localization Deal

Yuvraj — Wed, 27 May 2026 06:14:15 +0000

In a critical step for Colombia vaccine localization, SK Bioscience will execute a vaccine technology transfer with Colombia’s state-owned pharmaceutical enterprise, VECOL. The partnership focuses on building a local manufacturing site to align with the country’s national vaccine localization initiative. The agreement supports a broader state initiative jointly led by VECOL, the Colombian Ministry of […]

The post SK Bioscience Inks Colombia Vaccine Localization Deal first appeared on World Pharma Today.

Choosing Analytical Instruments for Pharma QC Labs

Yuvraj — Tue, 26 May 2026 06:36:16 +0000

Selecting the right laboratory equipment is a critical decision that directly impacts the efficiency, accuracy, and compliance of pharmaceutical operations. Evaluating analytical instruments pharma QC requirements involves a deep dive into technical specifications, vendor reliability, and the potential for long-term scalability. By choosing tools that integrate seamlessly with existing digital workflows and international regulatory standards, laboratory managers can ensure that their facility is equipped to handle the rigorous demands of modern drug testing and quality assurance. This strategic approach minimizes operational risk and ensures the delivery of safe and effective medications to patients globally.

The post Choosing Analytical Instruments for Pharma QC Labs first appeared on World Pharma Today.

Spectrophotometers Driving Accuracy in Drug Quality

Yuvraj — Tue, 26 May 2026 06:32:57 +0000

Precision in pharmaceutical analysis is fundamental to ensuring that every therapeutic agent delivered to a patient meets the highest safety and efficacy standards. The implementation of high-grade spectrophotometers drug quality control workflows provides a scientific basis for quantifying chemical properties and physical characteristics with unmatched reliability. By leveraging advanced spectral data, manufacturers can validate formulations and detect impurities early in the production cycle, thereby reinforcing the integrity of the global supply chain, ensuring regulatory compliance, and protecting the well-being of patients around the world.

The post Spectrophotometers Driving Accuracy in Drug Quality first appeared on World Pharma Today.

Bristol Myers Squibb Integrates AI to Advance Manufacturing Quality Systems

Yuvraj — Sat, 23 May 2026 06:17:43 +0000

Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy its Claude platform across global operations. This initiative moves beyond standard conversational tools, aiming to embed agentic AI capabilities directly into core workflows, including research, clinical development, and corporate functions. For industry executives, this move represents a significant effort to leverage advanced […]

The post Bristol Myers Squibb Integrates AI to Advance Manufacturing Quality Systems first appeared on World Pharma Today.

eschbach Unveils Seqonis Intelligent Operations Platform

Yuvraj — Fri, 22 May 2026 10:01:18 +0000

eschbach has renamed its flagship enterprise software platform, Shiftconnector, to Seqonis, marking a new phase in the product’s development after two decades of expansion across pharmaceutical, chemical and process manufacturing industries. The announcement was made during the Pharma Manufacturing World Summit and AVEVA World on May 19, 2026, as the company outlined its long-term strategy […]

The post eschbach Unveils Seqonis Intelligent Operations Platform first appeared on World Pharma Today.

Cell and Gene Therapy Manufacturing Entering GMP Era

Yuvraj — Tue, 19 May 2026 13:25:24 +0000

The rapid and profound maturation of the global biopharmaceutical sector is being clearly marked by cell and gene therapy manufacturing entering GMP era. This critical transition involves the large-scale implementation of rigorous and uncompromising Good Manufacturing Practice standards to ensure that these complex, "living" treatments are produced with a level of consistent quality and safety that meets international requirements. By adopting highly automated systems, closed-loop processing, and robust, data-driven regulatory frameworks, the industry is successfully overcoming the historical hurdles of scalability and biological variability, paving the way for these advanced therapies to reach much broader patient populations across the globe.

The post Cell and Gene Therapy Manufacturing Entering GMP Era first appeared on World Pharma Today.

How to Source the Best Color Spectrophotometers and Colorimeters for Pharma QC

Yuvraj — Mon, 18 May 2026 12:43:35 +0000

Color consistency is critical in pharmaceutical quality control (QC). Variations in tablet coatings, powders, liquids and packaging materials can indicate formulation inconsistencies, contamination risks or manufacturing deviations. To improve accuracy and reduce subjective visual inspection, pharmaceutical manufacturers increasingly rely on colorimeters and color spectrophotometers for standardized color analysis. For organizations searching for top-rated color spectrophotometers […]

The post How to Source the Best Color Spectrophotometers and Colorimeters for Pharma QC first appeared on World Pharma Today.

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

Yuvraj — Fri, 15 May 2026 10:50:47 +0000

A long-term development and commercial manufacturing agreement has been signed between Shilpa Medicare Limited and Switzerland-based NXI Therapeutics AG, extending the Indian pharmaceutical company’s role in global biologics and specialty therapeutics manufacturing. The agreement covers comprehensive chemistry, manufacturing and controls development, process scale-up, GMP clinical supply, and commercial manufacturing support for NXI’s immunomodulatory program. The […]

The post Shilpa Medicare, NXI Therapeutics AG Enters Partnership first appeared on World Pharma Today.

Novartis Expands Radioligand Therapy Manufacturing in US

Yuvraj — Thu, 14 May 2026 13:01:19 +0000

Swiss pharmaceutical company Novartis has started construction of a new manufacturing facility in Denton, Texas, as part of its previously announced $23 billion investment plan aimed at expanding research and production operations across the United States. The project, expected to be completed in 2028, will become the company’s first manufacturing site in Texas and its […]

The post Novartis Expands Radioligand Therapy Manufacturing in US first appeared on World Pharma Today.